Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $40.26 $52.54 Friday, 10th May 2024 RARE stock ended at $40.90. This is 0.776% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.23% from a day low at $40.26 to a day high of $41.56.
90 days $40.26 $54.55
52 weeks $31.52 $54.98

Historical Ultragenyx Pharmaceutical Inc. prices

Date Open High Low Close Volume
Dec 15, 2023 $46.00 $47.39 $45.35 $45.97 2 049 280
Dec 14, 2023 $45.57 $46.12 $44.73 $45.91 1 024 007
Dec 13, 2023 $43.44 $45.15 $43.28 $44.75 992 880
Dec 12, 2023 $40.52 $44.19 $39.76 $43.43 661 501
Dec 11, 2023 $40.69 $41.05 $39.42 $40.62 934 996
Dec 08, 2023 $42.39 $42.42 $40.34 $40.46 588 977
Dec 07, 2023 $41.22 $42.07 $40.60 $41.42 552 282
Dec 06, 2023 $42.24 $42.24 $40.92 $41.11 468 054
Dec 05, 2023 $40.87 $42.88 $40.32 $42.01 748 064
Dec 04, 2023 $39.43 $41.28 $39.43 $41.22 611 693
Dec 01, 2023 $38.80 $40.17 $38.70 $40.16 908 647
Nov 30, 2023 $39.59 $40.24 $38.03 $38.85 1 283 700
Nov 29, 2023 $38.51 $39.90 $38.51 $39.11 583 014
Nov 28, 2023 $38.39 $38.49 $37.21 $38.46 826 064
Nov 27, 2023 $39.00 $39.00 $37.96 $38.61 698 711
Nov 24, 2023 $38.35 $39.43 $38.28 $39.14 283 126
Nov 22, 2023 $39.22 $39.56 $37.85 $38.21 540 670
Nov 21, 2023 $39.10 $40.00 $38.39 $38.84 564 142
Nov 20, 2023 $40.11 $40.40 $38.31 $39.35 602 728
Nov 17, 2023 $39.46 $40.55 $38.89 $39.97 560 809
Nov 16, 2023 $38.90 $39.29 $38.14 $38.95 662 097
Nov 15, 2023 $38.33 $39.63 $38.15 $39.08 656 302
Nov 14, 2023 $36.79 $38.34 $36.51 $38.30 739 752
Nov 13, 2023 $34.49 $35.75 $34.06 $35.31 835 948
Nov 10, 2023 $35.01 $35.53 $34.26 $34.89 430 931
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT